From the ∗Department of Radiology, Fudan University Shanghai Cancer Center
†Department of Oncology, Shanghai Medical College, Fudan University
‡Department of Pathology, Fudan University Shanghai Cancer Center
§Department of Radiotherapy, Fudan University Huadong Hospital
∥Global Applied Science Laboratory, GE Healthcare, Shanghai, China.
Received for publication September 11, 2021; accepted January 3, 2022.
Correspondence to: Liangping Zhou, MD, Department of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, No. 270 Dong-An Rd, Shanghai, China, 200032 (e-mail: [email protected]). Yajia Gu, MD, Department of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, No. 270 Dong-An Rd, Shanghai, China, 200032 (e-mail: [email protected]).
The authors declare no conflict of interest.
The study was supported by the Special Fund for Clinical Research of Shanghai Municipal Health Commission (no 2020040270).
We certify that all authors have sufficiently participated in the work and take public responsibility for the appropriateness of the clinical experimental design and methods, as well as the analysis and interpretation of the data.
B.Z. and X.L. contributed equally and should be regarded as cofirst authors.
L.Z. and Y.G. contributed equally and should be regarded as co-correspondence authors.
